Clinical Trials for Unresectable Esophageal Adenocarcinoma

Find clinical trials for unresectable esophageal adenocarcinoma. Discover research opportunities and treatment options in your area.

4 Active Trials Found

Showing 4 trials on this page

Page 1 of 1

Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial

NCT ID: NCT06203600

The PARAMUNE Trial is studying how well a new treatment combining nivolumab with standard therapies works for people with advanced stomach or esophageal cancer. Nivolumab is a type of immunotherapy...

Recruiting

Phase: PHASE2 Type: interventional Locations: Chicago, Illinois, United States, New Haven, Connecticut, United States +378 more

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

NCT ID: NCT06251973

This clinical trial is studying a new treatment approach for people with advanced cancers of the esophagus, stomach, or the area where the esophagus meets the stomach. The treatment combines four d...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Basking Ridge, New Jersey, United States +5 more

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

NCT ID: NCT05677490

This clinical trial is comparing two different chemotherapy treatments for patients with advanced or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric cancer. The trial is...

Recruiting

Phase: PHASE3 Type: interventional Locations: Charleston, South Carolina, United States, Washington, District Of Columbia, United States +827 more

Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma

NCT ID: NCT05651594

This clinical trial is studying the potential benefits of adding a medication called propranolol to a combination treatment of pembrolizumab and standard chemotherapy for patients with esophageal o...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions